Literature DB >> 8432815

Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France.

P Mariani-Kurkdjian1, E Denamur, A Milon, B Picard, H Cave, N Lambert-Zechovsky, C Loirat, P Goullet, P J Sansonetti, J Elion.   

Abstract

In a French multicenter study, six verocytotoxin-producing Escherichia coli strains were isolated from the stools of 6 of 69 children suffering from hemolytic-uremic syndrome. All strains belonged to serotype O103:H2, a serotype commonly associated with diarrhea in weaned rabbits in France. To determine whether the strains from humans and rabbits were genetically related, they were compared by analyzing their esterase electropherotypes and the restriction fragment length polymorphisms of the ribosomal DNA regions. A common clonal origin of these pathogenic strains was suggested by their identical esterase electropherotypes and their identical ribotypes, in addition to their identical serotypes. However, strains from humans, which are cytotoxic for HeLa cells through the production of verocytotoxin type 1, do not show adhesion in vitro to HeLa 229 cells and cannot infect rabbits. On the other hand, strains from rabbits do not carry the verocytotoxin type 1 gene, are not cytotoxic for Hela cells, and adhere to ileal villi and HeLa 229 cells because of the expression of their 32-kDa adhesin. Our results therefore identify a clone of verocytotoxin-producing E. coli O103:H2 as a potential agent of hemolytic uremic syndrome in France. They further suggest that clones from humans and rabbits probably have a common origin but that adaptation to the two species occurred by different mechanisms. Thus, they eliminate the hypothesis that the species is horizontally transmitted between rabbits and humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432815      PMCID: PMC262753          DOI: 10.1128/jcm.31.2.296-301.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  R plasmid in Escherichia coli O103 coding for colonization of the rabbit intestinal tract.

Authors:  A Reynaud; M Federighi; D Licois; J F Guillot; B Joly
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Characterization of highly virulent Escherichia coli strains by ribosomal DNA restriction fragment length polymorphism.

Authors:  B Picard; N Picard-Pasquier; R Krishnamoorthy; P Goullet
Journal:  FEMS Microbiol Lett       Date:  1991-08-01       Impact factor: 2.742

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Restriction pattern of the major outer-membrane protein gene provides evidence for a homogeneous invasive group among ruminant isolates of Chlamydia psittaci.

Authors:  E Denamur; C Sayada; A Souriau; J Orfila; A Rodolakis; J Elion
Journal:  J Gen Microbiol       Date:  1991-11

5.  Molecular epidemiologic techniques in analysis of epidemic and endemic Shigella dysenteriae type 1 strains.

Authors:  N A Strockbine; J Parsonnet; K Greene; J A Kiehlbauch; I K Wachsmuth
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

6.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

Review 7.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

8.  DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; A Bourdois; P Mariani-Kurkdjian; J P Cezard; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  Scanning and transmission electron microscopic study of adherence of Escherichia coli O103 enteropathogenic and/or enterohemorrhagic strain GV in enteric infection in rabbits.

Authors:  D Licois; A Reynaud; M Federighi; B Gaillard-Martinie; J F Guillot; B Joly
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Attaching and effacing lesions in vivo and adhesion to tissue culture cells of Vero-cytotoxin-producing Escherichia coli belonging to serogroups O5 and O103.

Authors:  G A Hall; C R Dorn; N Chanter; S M Scotland; H R Smith; B Rowe
Journal:  J Gen Microbiol       Date:  1990-04
View more
  33 in total

1.  Virulence factors and phenotypical traits of verotoxin-producing Escherichia coli strains isolated from asymptomatic human carriers.

Authors:  R Stephan; F Untermann
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Importance of testing stool specimens for Shiga toxins.

Authors:  C H Park; H J Kim; D L Hixon
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

3.  Intimin types determined by heteroduplex mobility assay of intimin gene (eae)-positive Escherichia coli strains.

Authors:  Kenitiro Ito; Mariko Iida; Mitsugu Yamazaki; Kazuo Moriya; Sanae Moroishi; Jun Yatsuyanagi; Takayuki Kurazono; Noriaki Hiruta; Orn-Anong Ratchtrachenchai
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

4.  Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis.

Authors:  Lothar Beutin; Stefan Kaulfuss; Sylvia Herold; Eric Oswald; Herbert Schmidt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Control of enterohaemorrhagic Escherichia coli infection: the need for a network involving microbiological laboratories and clinical and public health institutions.

Authors:  H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

6.  Characterization of Escherichia coli strains from cases of childhood diarrhea in provincial southwestern Nigeria.

Authors:  I N Okeke; A Lamikanra; H Steinrück; J B Kaper
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children.

Authors:  F Allerberger; D Rossboth; M P Dierich; S Aleksic; H Schmidt; H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

8.  Use of a monoclonal antibody against an Escherichia coli O26 surface protein for detection of enteropathogenic and enterohemorrhagic strains.

Authors:  P Kerr; H Ball; B China; J Mainil; D Finlay; D Pollock; I Wilson; D Mackie
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

9.  Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.

Authors:  Jenny M Ritchie; Patrick L Wagner; David W K Acheson; Matthew K Waldor
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

10.  Phenotypic and genotypic characterization of verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.

Authors:  Musafiri Karama; Roger P Johnson; Robert Holtslander; Carlton L Gyles
Journal:  J Clin Microbiol       Date:  2008-09-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.